# Metformin

**Category:** pharmaceutical
**Evidence Grade:** B
**Risk Profile:** low

## Description
TAME trial ongoing — largest anti-aging drug trial

## Mechanisms of Action
- AMPK activation
- mTOR inhibition
- Glucose regulation

## Dosage
- **Standard:** 500-1000mg/day
- **Range:** 500-2000mg/day
- **Notes:** Start low, increase gradually. May deplete B12.

## Key Findings
- TAME trial ongoing — largest anti-aging drug trial
- Diabetics on metformin live longer than non-diabetic controls
- May blunt exercise benefits — timing matters

## Interactions


## Side Effects


## Contraindications
- Kidney disease (eGFR <30)
- Active alcoholism
- Severe liver disease

## Sources


## Suppliers


---
*Last updated: 2026-02-04T08:33:44.506Z*
